Larry Dillaha is the founder of Melt Pharmaceuticals. Melt Pharmaceuticals has raised $24M in total funding. Latest round: Series B. Backed by Harrow, Inc..
Larry Dillaha is the CEO of Melt Pharmaceuticals, a clinical-stage pharmaceutical company based in Nashville, Tennessee. The company focuses on developing non-opioid, non-IV sedation and analgesia therapeutics for human medical procedures. Melt Pharmaceuticals recently closed a $24 million Series B financing round to support the development of MELT-300, a non-IV, non-opioid tablet for procedural sedation.
Full founder directory · Investor directory · Company funding database · Fundraising library